23andMe
Former headquarters in Sunnyvale, California | |
| Company type | Public |
|---|---|
| OTC Pink: MEHCQ Nasdaq: ME | |
| ISIN | US90138Q3065 US90138Q4055 |
| Industry |
|
| Founded | April 2006 |
| Founders |
|
| Fate | Filed for Chapter 11 Bankruptcy in March 2025; in June 2025, TTAM Research Institute won the bid for 23andMe for $305 million. |
| Headquarters | South San Francisco, California |
Key people |
|
| Products |
|
| Services |
|
| Revenue | US$192 million (2024) |
| US$−681 million (2024) | |
| US$−666 million (2024) | |
| Total assets | US$395 million (2024) |
| Total equity | US$189 million (2024) |
| Owner | TTAM Research Institute |
Number of employees | 582 (2024) |
| Website | 23andme |
| Footnotes / references Financials as of March 31, 2024.[1] | |
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California.[1] It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping,[2] to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.[3]
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use.[4] Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.[5][6]
The company had a previously confrontational relationship with the United States Food and Drug Administration (FDA) due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval.[7][8] 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014,[9][10][11] and in the UK since December 2014.[12]
23andMe became a publicly traded company in 2021, via a merger with a Special Purpose Acquisition Company (SPAC), and soon had a market capitalization of US$6 billion.[13] By 2024, its valuation had fallen to 2% of that peak.[13] In March 2025, 23andMe filed for Chapter 11 bankruptcy, and CEO Anne Wojcicki resigned.[14] Due to the sensitive nature of data stored by 23andMe and privacy concerns due to bankruptcy filing,[15] the attorney general of California subsequently issued a consumer alert for its customers.[16]
On May 19, 2025, Regeneron agreed to buy 23andMe out of bankruptcy for $256 million.[17] In June, TTAM Research Institute, a non-profit founded by Anne Wojcicki, outbid Regeneron and won the bid for 23andMe for $305 million.[18]
On July 14, 2025, TTAM announced that it had completed the purchase of 23andMe's assets.[19]
- ^ a b "23andMe Holding Co. Fiscal 2024 Annual Report (Form 10-K)". U.S. Securities and Exchange Commission. May 30, 2024.
- ^ Cite error: The named reference
Wired2007was invoked but never defined (see the help page). - ^ "Fact Sheet". 23andMe. Archived from the original on January 19, 2013. Retrieved November 27, 2013.
- ^ "Autosomal SNP comparison chart - ISOGG Wiki". isogg.org. Retrieved September 4, 2022.
- ^ Cite error: The named reference
Timewas invoked but never defined (see the help page). - ^ Janzen, Tim; et al. "Family Tree DNA Learning Center". Autosomal DNA testing comparison chart. Gene by Gene.
- ^ Herper, Matthew (December 5, 2013). "23andMe Stops Offering Genetic Tests Related to Health". Forbes. Archived from the original on February 9, 2014. Retrieved December 6, 2013.
- ^ Pollack, Andrew (October 21, 2015). "23andMe Will Resume Giving Users Health Data". The New York Times. ISSN 0362-4331. Archived from the original on March 4, 2016. Retrieved October 21, 2015.
- ^ Ubelacker, Sheryl (October 1, 2014). "U.S. company launches genetic health and ancestry info service in Canada". Winnipeg Free Press. The Canadian Press. Retrieved October 7, 2014.
- ^ Hansen, Darah (October 2, 2014). "5Q: Anne Wojcicki, CEO 23andMe on knowing your DNA data (and being married to the boss of Google)". Yahoo Finance Canada. Retrieved October 7, 2014.
- ^ "23andme genetic testing service raises ethical questions". CBC News. October 2, 2014. Retrieved October 7, 2014.
- ^ Roberts, Michelle; Rincon, Paul (December 2, 2014). "Controversial DNA test comes to UK". BBC News. Retrieved December 2, 2014.
- ^ a b Winkler, Rolfe (January 31, 2024). "23andMe's Fall From $6 Billion to Nearly $0". Wall Street Journal.
- ^ "23andMe files for bankruptcy protection". www.bbc.com. March 24, 2025. Retrieved March 24, 2025.
- ^ "23andMe is filing for bankruptcy. Here's what it means for your genetic data". NPR. Retrieved April 13, 2025.
- ^ "Attorney General Bonta Urgently Issues Consumer Alert for 23andMe Customers". State of California - Department of Justice - Office of the Attorney General. March 21, 2025. Retrieved April 13, 2025.
- ^ Seal, Rolfe Winkler and Dean. "Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million". WSJ. Retrieved May 19, 2025.
- ^ Capoot, Ashley (June 13, 2025). "Anne Wojcicki to buy back 23andMe and its data for $305 million". CNBC. Retrieved June 14, 2025.
- ^ "TTAM Research Institute, A Nonprofit Public Benefit Corporation, Completes The Acquisition of 23andMe Assets". GlobeNewswire. Retrieved August 20, 2025.